June 30, 2017 / 5:38 AM / a year ago

Roche buys diabetes app-maker mySugr in digital health push

ZURICH, June 30 (Reuters) - Swiss drugmaker Roche said on Friday it is buying Vienna-based diabetes management platform mySugr for an undisclosed price as it presses into app-based digital health services for people suffering from the metabolic disorder.

MySugr, a privately held company that offers a logbook for mobile devices to help people manage their disease, had previously got funding from the Roche Venture Fund, Roche said in a statement.

Roche is among the world's largest makers of diabetes diagnostics, including finger pricks for patients to determine blood sugar levels. (Reporting by John Miller; Editing by Michael Shields)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below